Scarica l'app Stockscreener
4.95
1.79%
-0.09
Dopo l'orario di chiusura:
4.90
-0.05
-1.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$5.04
Aprire:
$5.04
Volume 24 ore:
2.76M
Relative Volume:
0.72
Capitalizzazione di mercato:
$1.22B
Reddito:
$427.68M
Utile/perdita netta:
$-58.06M
Rapporto P/E:
-20.78
EPS:
-0.2382
Flusso di cassa netto:
$-37.50M
1 W Prestazione:
-1.59%
1M Prestazione:
-2.94%
6M Prestazione:
-35.63%
1 anno Prestazione:
+16.75%
Intervallo 1D:
$4.92
$5.05
Intervallo di 1 settimana:
$4.905
$5.21
Portata 52W:
$4.075
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
4.95 | 1.25B | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx Inc (ARDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ARDX|Ardelyx Inc|Price:5.030|Chg%:-0.100 - TradingKey
Ardelyx Inc (ARDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ardelyx Inc (ARDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ardelyx (ARDX) Faces A Valuation Test, Is The Discount Too Wide? - simplywall.st
TradingKey - TradingKey
Ardelyx Inc (ARDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
Ardelyx Inc (ARDX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Ardelyx, Inc. Revenue Breakdown – NASDAQ:ARDX - TradingView
Ardelyx, Inc. (ARDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Ardelyx Inc (ARDX) Institutional Confidence - TradingKey
Ardelyx, Inc. (ARDX) stock price, news, quote and history - Yahoo Finance Singapore
Ardelyx Schedules Second Quarter 2026 Financial Results Webcast for August 6, 2026 - scanx.trade
ARDX: Ardelyx Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026 - The Manila Times
Ardelyx schedules webcast, call to discuss Q2 results and business update - Bitget
ARDX Q1 2026 Earnings: EPS Misses Estimates as Revenue Details Remain UnavailableBanking Earnings Report - po-news-eg.net
ETFs Investing in Ardelyx, Inc. Stocks - TradingView
How Investors Are Reacting To Ardelyx (ARDX) Hedge Fund Buying Despite Medicare Setback - simplywall.st
Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts - Yahoo Finance
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? - Stocktwits
High Growth Tech Stocks In The US Market - simplywall.st
Ardelyx (ARDX) Pulls Back As Growth Narrative Raises The Question Of Value - simplywall.st
Ardelyx CEO Michael Raab disposes of 41,668 common shares worth $210,884.22 - Bitget
Form 4 Ardelyx Inc For: 17 July By Investing.com - Investing.com Nigeria
Ardelyx CEO Michael Raab sells $210,923 in stock By Investing.com - Investing.com South Africa
Ardelyx CEO Michael Raab sells $210,923 in stock - Investing.com
Form 4 Ardelyx Inc For: 17 July - Investing.com India
Ardelyx CEO sells shares, exercises options | ARDX Insider Trading - Stock Titan
Lobbying Update: $500,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
Trading the Move, Not the Narrative: (ARDX) Edition - Stock Traders Daily
Ardelyx (ARDX) Receives a Buy from Wedbush - The Globe and Mail
Wedbush Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $19 - Moomoo
Lobbying Update: $20,000 of ARDELYX INC lobbying was just disclosed - Quiver Quantitative
Ardelyx Secures New $50 Million Term F Loan - The Globe and Mail
Ardelyx (NASDAQ: ARDX) draws $50M Term F loan maturing in 2030 - Stock Titan
Ardelyx: The Market Is Right To Discount This Revenue Growth - Seeking Alpha
Price to book forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Enterprise value to revenue forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Enterprise value to EBITDA forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Price to sales forward of Ardelyx, Inc. – NASDAQ:ARDX - TradingView
Price to earnings forward of Ardelyx, Inc. – TRADEGATE:41X - TradingView
Ardelyx, Inc.'s (NASDAQ:ARDX) Shift From Loss To Profit - 富途牛牛
Ardelyx (ARDX) Faces New Medicare Rules For Xphozah After Court Ruling - simplywall.st
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ardelyx Inc Azioni (ARDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Jul 15 '26 |
Sale |
5.06 |
41,668 |
210,923 |
1,678,366 |
| Williams Laura A | Chief Patient Officer |
Jun 18 '26 |
Option Exercise |
0.99 |
31,000 |
30,690 |
460,093 |
| Williams Laura A | Chief Patient Officer |
Jun 18 '26 |
Sale |
5.99 |
81,898 |
490,487 |
378,195 |
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):